Entity > Corporation > US > New York City New York > Exelixis

About Exelixis

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Exelixis

Company Attribute Value
Name Exelixis
Url exelixis
Google google
Wikidata wikidata



New York City, US
18 Sep 2023

New York City, US
18 Sep 2023


Page: 1 Desktop | Laptop Devices

Shaping the Future of Oncology for Patients l Exelixis
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the ...
https://www.linkedin.com › company › exelixis
Mar 16, 2012 — Exelixis | 45035 followers on LinkedIn. Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give ...
https://en.wikipedia.org › wiki › Exelixis
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. ...
Exelixis (@ExelixisInc) · Twitter
https://finance.yahoo.com › quote › EXEL
Exelixis, Inc. (EXEL) Stock Price, News, Quote & History
Find the latest Exelixis, Inc. (EXEL) stock quote, history, news and other vital information to help you with your stock trading and investing.
Exelixis, Inc. (EXEL) Company Profile & Facts
See the company profile for Exelixis, Inc. (EXEL) including business summary, industry/sector information, number of employees, business summary, ...
https://www.globaldata.com › All Companies
Exelixis Inc Company Profile - Exelixis Inc Overview
Exelixis Inc (Exelixis) is a biopharmaceutical company that focuses on the development and commercialization of small molecule therapies for the treatment ...
https://www.cnbc.com › quotes › EXEL
EXEL: Exelixis Inc - Stock Price, Quote and News
Get Exelixis Inc (EXEL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Related Searches
Related Searches
exelixis meaning
exelixis drugs
Exelixis stock price
Knowledge Panel
Knowledge Panel

Exelixis (Biotechnology company)


Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

  • Stock price : EXEL (NASDAQ) $21.81 -0.46 (-2.07%)Sep 15, 4:00 PM EDT - Disclaimer
  • Headquarters : Alameda, CA
  • CEO : Michael M. Morrissey (Jul 2010–)
  • Subsidiaries : Exelixis U.S., LLC, Exelixis Plant Sciences, Inc, MORE
  • Founded : November 15, 1994, Cambridge, MA
  • Revenue : 1.435 billion USD (2021)
  • President : Michael M. Morrissey

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 89677